Display Settings:

Format

Send to:

Choose Destination
    J Acquir Immune Defic Syndr. 1990;3(11):1074-7.

    A report of eight HIV-seropositive patients with major depression responding to fluoxetine.

    Source

    Department of Psychiatry, University of Southern California School of Medicine, Los Angeles.

    Abstract

    This pilot study examined the effectiveness of fluoxetine in depressed human immunodeficiency virus (HIV)-seropositive asymptomatic patients. Eight patients, participating in an AZT trial who met criteria for major depression syndrome (DSM-III-R), were treated with fluoxetine (20 or 40 mg/day) for 4 weeks. Initially, mean Hamilton Depression scores were 23.8 (range of 17-31), and improved to 6.4 (range of 3-10). All subjects maintained their remission over a 2-month follow-up. Fluoxetine treatment may be effective in treating major depression in HIV-seropositive asymptomatic patients.

    PMID:
    2213507
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk